Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Pancreatic Neoplasms: HELP
James C. Yao
Based on 39 articles published since 2007
||||
Expertise Level
The expertise of James C. Yao ranks in the
  • Top 0.064%
  • ... of 90,771 published authors worldwide on Pancreatic Neoplasms
  • ... from 2007 through 2018
  • ... based on contributions to 39 articles on the topic.
Graphical view (beta)
Uncounted papers?
Get your prestigious
Expert badge
similar to this:
 
Aliases Yao, James   ·   Yao, James C   ·   Yao, J C
Work Locations
Details
Most likely:    University of Texas Houston   Contact    
2017
  • Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA. · Department of Gastroenterology and Pancreatology University of Paris VII and Beaujon Hospital, Paris, France. · Department of Digestive Oncology, University Hospitals Gasthuisberg/Leuven and KU Leuven, Leuven, Belgium. · Department of Medical Oncology, Edouard Herriot Hospital, Lyon, France. · Department of Medical Oncology, University of Manchester/The Christie Hospital, Manchester, UK. · Department of Endocrine Oncology, Erasmus University Medical Center, Rotterdam, The Netherlands. · Department of Hepatology and Gastroenterology, Charité University of Medicine, Berlin, Germany. · Department of Oncology, Novartis AG, Basel, Switzerland. · Department of Oncology, Novartis Pharmaceuticals Corporation, East Hanover, USA. · Department of Medical Oncology, Catalan Institute of Oncology, IDIBELL, Hospital of Barcelona, Barcelona, Spain. · Department of Gastroenterology Saint-Luc University Hospital, Brussels, Belgium. · Department of Gastrointestinal Medical Oncology and Neuroendocrine Tumors, European Institute of Oncology, Milan, Italy. · Department of Oncology, St. Andrew Hospital, Bordeaux, France. · Department of Medical Oncology, Vall d'Hebron University Hospital, Barcelona, Spain. · Department of Oncology, Cancer Institute of the State of São Paulo, São Paulo, Brazil. · Department of Gastrointestinal and Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, USA. · Pubmed 28327907
  • Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston. · Department of Health Services Research, The University of Texas MD Anderson Cancer Center, Houston. · Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston. · Pubmed 28448665
  • Department of Hepatobiliary Pancreatic Surgery, The First Hospital of Jilin University, Changchun, Jilin, China. · Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Surgery, Levine Cancer Institute, Charlotte, NC, USA. · Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Departments of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Pubmed 28273369
  • Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Unit 1484, PO Box 301402, Houston, TX, 77230-1402, USA. · Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Unit 1484, PO Box 301402, Houston, TX, 77230-1402, USA. · Pubmed 27634306
2016
  • Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Hepatobiliary Pancreatic Surgery, The First Hospital of Jilin University, Changchun, Jilin, China. · Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Departments of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Pubmed 27256431
2015
  • Department of Gastrointestinal Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. · Department of Biostatistics, University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Diagnostic Radiology, University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Gastrointestinal Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address: · Pubmed 25956795
  • Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Unit 1484, PO Box 301402, Houston, 77230-1402, TX, USA. · Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Unit 1484, PO Box 301402, Houston, 77230-1402, TX, USA. · Pubmed 26282850
2013
  • Departments of Gastrointestinal Medical Oncology and Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 23436795
2011
  • Department of Gastrointestinal Medical Oncology, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Box 426, Houston, Texas 77030, USA. · Pubmed 21994954
  • University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 21306238
  • Department of Gastrointestinal Medical Oncology, University of Texas, M. D. Anderson Cancer Center, Houston, Texas 77030, USA. · Pubmed 21828238
2010
  • Department of Gastrointestinal Medical Oncology, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Blvd, Unit 426, Houston, TX 77030, USA. · Pubmed 19933912
  • University of Texas MD Anderson Cancer Center, USA. · Pubmed 21302643
2008
  • Department of Gastrointestinal Medical Oncology, Unit 426, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA. · Pubmed 18779618
2007
  • Department of Gastrointestinal Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 17382271
  • Department of Gastrointestinal Medical Oncology, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, Texas 77030, USA. · Pubmed 17896148
2017
  • From the *Department of Hepatology and Gastroenterology, Charité Universitätsmedizin Berlin/Campus Virchow Klinikum, Berlin, Germany; †Novartis Pharmaceuticals Corporation, East Hanover, NJ; ‡Department of Medical Oncology, University Medical Center, University of Groningen, Groningen, The Netherlands; §Oncologie Endocrinienne et Médecine Nucléaire, Institut Gustave-Roussy, Villejuif, France; and ∥Department of Gastrointestinal Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX. · Pubmed 28609362
2016
  • James C. Yao, University of Texas MD Anderson Cancer Center, Houston, TX; Maurizio Voi, Wei He, and David Chen, Novartis, East Hanover, NJ; Timothy Hobday, Mayo Clinic College of Medicine, Rochester, MN; Rodney Pommier, Oregon Health & Science University, Portland, OR; Marianne Pavel, Charité Universitätsmedizin, Berlin, Germany; Catherine Lombard-Bohas, Hôpital Edouard Herriot, Hospices Civils de Lyon, Lyon, France; Eric Van Cutsem, University Hospitals Gasthuisberg/Leuven and KU Leuven, Leuven, Belgium; Ulrike Brandt, Novartis Pharma AG, Basel, Switzerland; Jaume Capdevila, Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain; Elisabeth G. E. de Vries, UMCG, University of Groningen, Groningen, Netherlands; Paola Tomassetti, University of Bologna, Bologna, Italy; and Kjell Öberg, Uppsala University Hospital, Uppsala, Sweden. · Pubmed 27621394
  • From the Department of Gastrointestinal Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX. · Pubmed 27295529
2015
  • Department of Gastrointestinal Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas 77030; email: , · Pubmed 25341008
  • From the *Department of Medical Oncology, Hôpital Edouard Herriot, Hospices Civils de Lyon, Lyon, France; †Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX; ‡Department of Oncology, Mayo Clinic College of Medicine, Rochester, MN; §Digestive Oncology, University Hospitals Gasthuisberg/Leuven, Leuven, Belgium; ∥Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, CA; ¶Department of Oncology Biometrics and Data, and #Department of Oncology, Novartis Pharmaceuticals Corporation, East Hanover, NJ; **Department of Medical Oncology, The Ohio State University, Columbus, OH; ††Department of Medical Oncology, Vall d'Hebron University Hospital, Barcelona, Spain; and ‡‡Division of Surgical Oncology, Oregon Health & Science University, Portland, OR. · Pubmed 25479584
2014
  • From the Departments of Pathology (Drs Estrella, Broaddus, Wang, and Rashid), Immunology (Ms Mathews), Biostatistics (Ms Milton), and Gastrointestinal Medical Oncology, (Dr Yao), The University of Texas MD Anderson Cancer Center, Houston, Texas. · Pubmed 25076292
  • From the Departments of *Pathology, †Biostatistics, and ‡Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX. · Pubmed 25058880
  • Department of Health Services Research, The University of Texas MD Anderson Cancer Center, Houston, Texas; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Pubmed 24676892
2012
  • Department of Diagnostic Radiology, University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 22915400
  • Department of Gastroenterology, MD Anderson Cancer Center, 1515-Holcombe Blvd., Unit #1466, Houston, TX 77030, USA. · Pubmed 21964743
2010
  • Department of Gastrointestinal Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas 77030, USA. · Pubmed 20086170
2008
  • Department of Gastrointestinal Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 18491401
  • Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 17943967
2007
  • Department of Pathology, MD Anderson Cancer Center, The University of Texas, 1515 Holcombe Boulevard, Box 85, Houston, Texas 77030-4095, USA. · Pubmed 17639061
  • Department of Gastrointestinal Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA. · Pubmed 17510417
  • Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030-4095, USA. · Pubmed 17483816
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 39 total) written by James C. Yao about Pancreatic Neoplasms:

  • Everolimus Effect on Gastrin and Glucagon in Pancreatic Neuroendocrine Tumors. 2017
  • A randomized, open-label, phase 2 study of everolimus in combination with pasireotide LAR or everolimus alone in advanced, well-differentiated, progressive pancreatic neuroendocrine tumors: COOPERATE-2 trial. 2017
  • Trends in the Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors in the United States. 2017
  • Is estrogen exposure a protective factor for pancreatic neuroendocrine tumours in female patients with multiple endocrine neoplasia syndrome type 1? 2017
  • Role of Fluorouracil, Doxorubicin, and Streptozocin Therapy in the Preoperative Treatment of Localized Pancreatic Neuroendocrine Tumors. 2017
  • Everolimus for the Treatment of Advanced Pancreatic Neuroendocrine Tumors: Overall Survival and Circulating Biomarkers From the Randomized, Phase III RADIANT-3 Study. 2016
  • Future Directions in the Biology of Neuroendocrine Tumors. 2016
  • Utility of chromogranin A, pancreatic polypeptide, glucagon and gastrin in the diagnosis and follow-up of pancreatic neuroendocrine tumours in multiple endocrine neoplasia type 1 patients. 2016
  • A tale of two tumors: treating pancreatic and extrapancreatic neuroendocrine tumors. 2015
  • Pazopanib and depot octreotide in advanced, well-differentiated neuroendocrine tumours: a multicentre, single-group, phase 2 study. 2015
Show List of Full Article Records
Google Searches

Learn more about James C. Yao using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
University of Texas Houston
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
University of Texas Houston
2017
  • Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA. · Department of Gastroenterology and Pancreatology University of Paris VII and Beaujon Hospital, Paris, France. · Department of Digestive Oncology, University Hospitals Gasthuisberg/Leuven and KU Leuven, Leuven, Belgium. · Department of Medical Oncology, Edouard Herriot Hospital, Lyon, France. · Department of Medical Oncology, University of Manchester/The Christie Hospital, Manchester, UK. · Department of Endocrine Oncology, Erasmus University Medical Center, Rotterdam, The Netherlands. · Department of Hepatology and Gastroenterology, Charité University of Medicine, Berlin, Germany. · Department of Oncology, Novartis AG, Basel, Switzerland. · Department of Oncology, Novartis Pharmaceuticals Corporation, East Hanover, USA. · Department of Medical Oncology, Catalan Institute of Oncology, IDIBELL, Hospital of Barcelona, Barcelona, Spain. · Department of Gastroenterology Saint-Luc University Hospital, Brussels, Belgium. · Department of Gastrointestinal Medical Oncology and Neuroendocrine Tumors, European Institute of Oncology, Milan, Italy. · Department of Oncology, St. Andrew Hospital, Bordeaux, France. · Department of Medical Oncology, Vall d'Hebron University Hospital, Barcelona, Spain. · Department of Oncology, Cancer Institute of the State of São Paulo, São Paulo, Brazil. · Department of Gastrointestinal and Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, USA. · Pubmed 28327907
  • Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston. · Department of Health Services Research, The University of Texas MD Anderson Cancer Center, Houston. · Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston. · Pubmed 28448665
  • Department of Hepatobiliary Pancreatic Surgery, The First Hospital of Jilin University, Changchun, Jilin, China. · Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Surgery, Levine Cancer Institute, Charlotte, NC, USA. · Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Departments of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Pubmed 28273369
  • Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Unit 1484, PO Box 301402, Houston, TX, 77230-1402, USA. · Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Unit 1484, PO Box 301402, Houston, TX, 77230-1402, USA. · Pubmed 27634306
2016
  • Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Hepatobiliary Pancreatic Surgery, The First Hospital of Jilin University, Changchun, Jilin, China. · Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Departments of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Pubmed 27256431
2015
  • Department of Gastrointestinal Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. · Department of Biostatistics, University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Diagnostic Radiology, University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Gastrointestinal Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address: · Pubmed 25956795
  • Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Unit 1484, PO Box 301402, Houston, 77230-1402, TX, USA. · Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Unit 1484, PO Box 301402, Houston, 77230-1402, TX, USA. · Pubmed 26282850
2013
  • Departments of Gastrointestinal Medical Oncology and Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 23436795
2011
  • Department of Gastrointestinal Medical Oncology, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Box 426, Houston, Texas 77030, USA. · Pubmed 21994954
  • University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 21306238
  • Department of Gastrointestinal Medical Oncology, University of Texas, M. D. Anderson Cancer Center, Houston, Texas 77030, USA. · Pubmed 21828238
2010
  • Department of Gastrointestinal Medical Oncology, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Blvd, Unit 426, Houston, TX 77030, USA. · Pubmed 19933912
  • University of Texas MD Anderson Cancer Center, USA. · Pubmed 21302643
2008
  • Department of Gastrointestinal Medical Oncology, Unit 426, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA. · Pubmed 18779618
2007
  • Department of Gastrointestinal Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 17382271
  • Department of Gastrointestinal Medical Oncology, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, Texas 77030, USA. · Pubmed 17896148
2017
  • From the *Department of Hepatology and Gastroenterology, Charité Universitätsmedizin Berlin/Campus Virchow Klinikum, Berlin, Germany; †Novartis Pharmaceuticals Corporation, East Hanover, NJ; ‡Department of Medical Oncology, University Medical Center, University of Groningen, Groningen, The Netherlands; §Oncologie Endocrinienne et Médecine Nucléaire, Institut Gustave-Roussy, Villejuif, France; and ∥Department of Gastrointestinal Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX. · Pubmed 28609362
2016
  • James C. Yao, University of Texas MD Anderson Cancer Center, Houston, TX; Maurizio Voi, Wei He, and David Chen, Novartis, East Hanover, NJ; Timothy Hobday, Mayo Clinic College of Medicine, Rochester, MN; Rodney Pommier, Oregon Health & Science University, Portland, OR; Marianne Pavel, Charité Universitätsmedizin, Berlin, Germany; Catherine Lombard-Bohas, Hôpital Edouard Herriot, Hospices Civils de Lyon, Lyon, France; Eric Van Cutsem, University Hospitals Gasthuisberg/Leuven and KU Leuven, Leuven, Belgium; Ulrike Brandt, Novartis Pharma AG, Basel, Switzerland; Jaume Capdevila, Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain; Elisabeth G. E. de Vries, UMCG, University of Groningen, Groningen, Netherlands; Paola Tomassetti, University of Bologna, Bologna, Italy; and Kjell Öberg, Uppsala University Hospital, Uppsala, Sweden. · Pubmed 27621394
  • From the Department of Gastrointestinal Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX. · Pubmed 27295529
2015
  • Department of Gastrointestinal Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas 77030; email: , · Pubmed 25341008
  • From the *Department of Medical Oncology, Hôpital Edouard Herriot, Hospices Civils de Lyon, Lyon, France; †Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX; ‡Department of Oncology, Mayo Clinic College of Medicine, Rochester, MN; §Digestive Oncology, University Hospitals Gasthuisberg/Leuven, Leuven, Belgium; ∥Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, CA; ¶Department of Oncology Biometrics and Data, and #Department of Oncology, Novartis Pharmaceuticals Corporation, East Hanover, NJ; **Department of Medical Oncology, The Ohio State University, Columbus, OH; ††Department of Medical Oncology, Vall d'Hebron University Hospital, Barcelona, Spain; and ‡‡Division of Surgical Oncology, Oregon Health & Science University, Portland, OR. · Pubmed 25479584
2014
  • From the Departments of Pathology (Drs Estrella, Broaddus, Wang, and Rashid), Immunology (Ms Mathews), Biostatistics (Ms Milton), and Gastrointestinal Medical Oncology, (Dr Yao), The University of Texas MD Anderson Cancer Center, Houston, Texas. · Pubmed 25076292
  • From the Departments of *Pathology, †Biostatistics, and ‡Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX. · Pubmed 25058880
  • Department of Health Services Research, The University of Texas MD Anderson Cancer Center, Houston, Texas; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Pubmed 24676892
2012
  • Department of Diagnostic Radiology, University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 22915400
  • Department of Gastroenterology, MD Anderson Cancer Center, 1515-Holcombe Blvd., Unit #1466, Houston, TX 77030, USA. · Pubmed 21964743
2010
  • Department of Gastrointestinal Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas 77030, USA. · Pubmed 20086170
2008
  • Department of Gastrointestinal Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 18491401
  • Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 17943967
2007
  • Department of Pathology, MD Anderson Cancer Center, The University of Texas, 1515 Holcombe Boulevard, Box 85, Houston, Texas 77030-4095, USA. · Pubmed 17639061
  • Department of Gastrointestinal Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA. · Pubmed 17510417
  • Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030-4095, USA. · Pubmed 17483816
19 Other Locations Show
Yearly article counts 053451344136
 
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.